The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have ...

With U.S. diagnoses of Parkinson's expected to reach 1.2 million by 2030, research is in full swing, and treatments ...

Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...

Neurologists at Florida Atlantic University have launched a new research tool combining focused ultrasound and magnetic ...

A condition that compels people to move their legs could indicate they have a greater chance of developing Parkinson's ...

Common drugs used to treat chronic ailments appear to delay the onset of Parkinson’s symptoms Aspirin, ibuprofen, statins and beta blockers were all associated with a delay in Parkinson’s symptoms ...

Restless legs syndrome, a condition affecting millions of Americans, may be tied to increased Parkinson’s risk, according to ...

Parkinson’s patients taking antipsychotic medications have a significant increased risk of death, according to a new study published in JAMA Neurology and covered by News Medical. For the study, ...

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...